These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31513833)

  • 1. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs.
    Ji J; Xu J; Zhao S; Liu F; Qi J; Song Y; Ren J; Wang T; Dou H; Hou Y
    Clin Sci (Lond); 2016 Aug; 130(16):1453-67. PubMed ID: 27231253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDSC-derived S100A8/9 contributes to lupus pathogenesis by promoting TLR7-mediated activation of macrophages and dendritic cells.
    Yang Y; Zhang X; Jing L; Xiao Y; Gao Y; Hu Y; Jia S; Zhou G; Xiong H; Dong G
    Cell Mol Life Sci; 2024 Mar; 81(1):110. PubMed ID: 38429401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.
    Schwarting A; Relle M; Meineck M; Föhr B; Triantafyllias K; Weinmann A; Roth W; Weinmann-Menke J
    Lupus; 2018 Feb; 27(2):243-256. PubMed ID: 28659046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
    Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
    Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
    Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J; Xu J; Li F; Li X; Gong W; Song Y; Dou H; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
    Li D; Lu L; Kong W; Xia X; Pan Y; Li J; Wang J; Wang T; Liang J; Dou H; Hou Y
    Cell Death Dis; 2021 Sep; 12(9):829. PubMed ID: 34480018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
    Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
    J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering receptor expressed on myeloid cells-1 (TREM-1) deficiency augments BAFF production to promote lupus progression.
    Liu CJ; Tsai CY; Chiang SH; Tang SJ; Chen NJ; Mak TW; Sun GH; Sun KH
    J Autoimmun; 2017 Mar; 78():92-100. PubMed ID: 28089248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.
    Yang L; Zhang T; Wang P; Chen W; Liu W; He X; Zhang Y; Jin S; Luo Z; Zhang Z; Wang X; Liu J
    Cell Biol Toxicol; 2023 Dec; 39(6):3287-3304. PubMed ID: 37804401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Zheng Y; Tian X; Wang T; Xia X; Cao F; Tian J; Xu P; Ma J; Xu H; Wang S
    Mol Cancer; 2019 Mar; 18(1):61. PubMed ID: 30925926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
    Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
    Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus.
    Zhang F; Wu L; Qian J; Qu B; Xia S; La T; Wu Y; Ma J; Zeng J; Guo Q; Cui Y; Yang W; Huang J; Zhu W; Yao Y; Shen N; Tang Y
    J Autoimmun; 2016 Dec; 75():96-104. PubMed ID: 27481557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.
    Wu H; Zhen Y; Ma Z; Li H; Yu J; Xu ZG; Wang XY; Yi H; Yang YG
    Sci Transl Med; 2016 Mar; 8(331):331ra40. PubMed ID: 27009269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
    Li D; Qi J; Wang J; Pan Y; Li J; Xia X; Dou H; Hou Y
    Free Radic Biol Med; 2019 Nov; 143():260-274. PubMed ID: 31419476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
    Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
    Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.